ID
27231
Beschrijving
Study ID: 101468/188 Clinical Study ID: SKF-101468/188 Study Title:A Study of the Maintained Efficacy and Safety of Ropinirole Versus Placebo in the Long Term Treatment of Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Parkinson Disease Module: Baseline Signs and Symptoms
Trefwoorden
Versies (1)
- 03-11-17 03-11-17 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
3 november 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
GSK Ropinirole in Patients Suffering from Restless Legs Syndrome 101468/188
Baseline Signs and Symptoms
- StudyEvent: ODM
Similar models
Baseline Signs and Symptoms
- StudyEvent: ODM
C1442488 (UMLS CUI-2)
C1442488 (UMLS CUI [1,2])
C0037088 (UMLS CUI [2])
C1301880 (UMLS CUI [2])
C0441471 (UMLS CUI [3,1])
C1442488 (UMLS CUI [3,2])
C1522314 (UMLS CUI [2])
C0441471 (UMLS CUI [3,1])
C1442488 (UMLS CUI [3,2])
C0441471 (UMLS CUI [2,1])
C1442488 (UMLS CUI [2,2])
C0441471 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
C0441471 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
C0441471 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
C0441471 (UMLS CUI [2,1])
C1442488 (UMLS CUI [2,2])
C0441471 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])